Linvencovir: Paving the way for functional cure in hepatitis B

키워드

참고문헌 (10)

1. Lok AS, "Hepatitis B cure : From discovery to regulatory approval", Hepatology, 66, pp.1296~1313 (2017)
2. Mak LY, "The role of different viral biomarkers on the management of chronic hepatitis B", Clin Mol Hepatol, 29, pp.263~276 (2023)
3. Korean Association for the Study of the Liver(KASL), "KASL clinical practice guidelines for management of chronic hepatitis B", Clin Mol Hepatol, 28, pp.276~331 (2022)
4. Terrault NA, "Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 hepatitis B guidance", Hepatology, 67, pp.1560~1599 (2018)
5. Lee CH, "Core indicators related to the elimination of hepatitis B and C virus infection in South Korea : A nationwide study", Clin Mol Hepatol, 29, pp.779~793 (2023)
6. Yuen MF, "Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection", J Hepatol, 77, pp.642~652 (2022)
7. Yuen MF, "Efficacy and safety of bepirovirsen in chronic hepatitis B infection", N Engl J Med, 387, pp.1957~1968 (2022)
8. Hou J, "Efficacy, safety and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients", Clin Mol Hepatol, 30, pp.191~205 (2024)
9. Feng S, "A Five-in-one first-in-human study to assess safety, tolerability, and pharmacokinetics of RO7049389, an inhibitor of hepatitis B virus capsid assembly, after single and multiple ascending doses in healthy participants", Antimicrob Agents Chemother, 64, pp.e01323-20~ (2020)
10. Yuen MF, "Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection : a multicentre, randomised, placebo-controlled, phase 1 trial", Lancet Gastroenterol Hepatol, 6, pp.723~732 (2021)

관련 논문AI추천